Dermatological Adverse Effects of Chemotherapeutic Agents: Experience from a Tertiary Centre

    Parvaiz Anwar Rather, Hussain Mir M, Subhash Kaul, Vikas Roshan, Jilu Mathews, B. K. Sharma
    Image of study
    TLDR About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.
    In a study involving 125 oncology patients at a tertiary center, 27 (21.6%) experienced dermatological adverse effects from chemotherapy, with 45 side effects noted in total. Hair loss, specifically anagen and telogen effluvium, was the most common side effect, followed by skin issues like diffuse hyperpigmentation, xerosis, and hand-foot syndrome. Nail discoloration and oral mucositis were also observed. The study found that while these side effects were common, they were not typically severe enough to stop treatment. It highlighted the need for awareness and management of these effects by healthcare professionals to reduce morbidity and improve the quality of life for cancer survivors. The study also acknowledged limitations in pinpointing exact drugs causing certain side effects due to the use of combination chemotherapy regimens.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Hair Disorders

      research Hair Disorders

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.
      Female Adolescent Hair Disorders

      research Female Adolescent Hair Disorders

      20 citations, July 2009 in “Journal of Pediatric and Adolescent Gynecology”
      Quick treatment of hair disorders in teenage girls is important because of the emotional effects.
      Skin Toxicity of Anti-Cancer Therapy

      research Skin Toxicity of Anti-Cancer Therapy

      19 citations, October 2008 in “Journal der Deutschen Dermatologischen Gesellschaft”
      Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.